POLY MEDICURE
|
POLY MEDICURE Last 5 Year Cashflow Statement History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Profit Before Tax | ₹237 Cr | ₹195 Cr | ₹180 Cr | ₹126 Cr | ₹99 Cr |
Adjustment | ₹61 Cr | ₹39 Cr | ₹44 Cr | ₹51 Cr | ₹44 Cr |
Changes In working Capital | ₹-50 Cr | ₹-63 Cr | ₹-61 Cr | ₹-12 Cr | ₹-8.69 Cr |
Cash Flow after changes in Working Capital | ₹249 Cr | ₹171 Cr | ₹163 Cr | ₹164 Cr | ₹134 Cr |
Cash Flow from Operating Activities | ₹191 Cr | ₹123 Cr | ₹119 Cr | ₹128 Cr | ₹106 Cr |
Cash Flow from Investing Activities | ₹-179 Cr | ₹-85 Cr | ₹-436 Cr | ₹-107 Cr | ₹-101 Cr |
Cash Flow from Financing Activities | ₹-13 Cr | ₹-35 Cr | ₹317 Cr | ₹-21 Cr | ₹-5.13 Cr |
Net Cash Inflow / Outflow | ₹-0.70 Cr | ₹2.80 Cr | ₹0.10 Cr | ₹0.54 Cr | ₹0.62 Cr |
Opening Cash & Cash Equivalents | ₹7.76 Cr | ₹4.95 Cr | ₹4.86 Cr | ₹4.32 Cr | ₹3.70 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
Closing Cash & Cash Equivalent | ₹7.06 Cr | ₹7.76 Cr | ₹4.95 Cr | ₹4.86 Cr | ₹4.32 Cr |
Compare Cashflow Statement of peers of POLY MEDICURE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
POLY MEDICURE | ₹17,339.5 Cr | 3.8% | 14.7% | 84.5% | Stock Analytics | |
PREVEST DENPRO | ₹465.7 Cr | 0.6% | -10.3% | -6.5% | Stock Analytics | |
NURECA | ₹272.4 Cr | 1.5% | -5.8% | -16.8% | Stock Analytics |
POLY MEDICURE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
POLY MEDICURE | 3.8% |
14.7% |
84.5% |
SENSEX | 1.9% |
2.1% |
21.7% |
You may also like the below Video Courses